MelphalanAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsAntineoplastic Agents, AlkylatingDoxorubicinCisplatinChemotherapy, AdjuvantCombined Modality TherapyChemotherapy, Cancer, Regional PerfusionCyclophosphamidePaclitaxelTreatment OutcomeDrug Resistance, NeoplasmEtoposideDeoxycytidineDrug SynergismCell Line, TumorLung NeoplasmsNeoplasmsAntimetabolites, AntineoplasticBreast NeoplasmsMultiple MyelomaAntibiotics, AntineoplasticTaxoidsDrug Administration ScheduleDose-Response Relationship, DrugTransplantation, AutologousDacarbazineCell SurvivalAntineoplastic Agents, PhytogenicDrug Screening Assays, AntitumorApoptosisDisease-Free SurvivalCarcinoma, Non-Small-Cell LungSurvival AnalysisCarmustineXenograft Model Antitumor AssaysSurvival RateTumor Cells, CulturedTime FactorsNeoadjuvant TherapyHematopoietic Stem Cell TransplantationMyeloablative AgonistsNeoplasm StagingPrognosisDrug Delivery SystemsCarboplatinFluorouracilAntibodies, MonoclonalThiotepaMethotrexateMice, SCIDCell ProliferationMice, NudeCytarabineCaspase 3Neoplasm Recurrence, LocalVinblastineTransplantation ConditioningSalvage TherapyLomustineIfosfamideCell CycleBleomycinInduction ChemotherapyAmyloidosisFollow-Up StudiesHodgkin Disease